A total of six surface antigens (CD62L, CD54, CD49c, CD49d, CD38, and CD79b) and prognostic risk models were put in place to diagnose and predict the OS for CLL (Zucchetto et al., 2006). The gene discussed is SELL; the disease is B-cell chronic lymphocytic leukemia.